Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating aplastic anemia

A technique for aplastic anemia, applied in drug combinations, blood diseases, pharmaceutical formulations, etc., can solve problems such as transfusional hemochromatosis and no significant effect

Active Publication Date: 2012-10-17
NANTONG HONGCI PHARMA
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, repeated blood transfusions are likely to cause transfusional hemochromatosis, and only using G-CSF, EPO and other hematopoietic growth factors to promote hematopoiesis in patients with aplastic anemia has no significant clinical effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating aplastic anemia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Embodiment 1, raw material drug weight ratio: Astragalus 6g, Polygonatum 8g, Ligustrum lucidum 8g, One-leaf Hagi 6g, ox horn gill 6g, Atractylodes rhizome 8g, Angelica 6g, 9 layers of wind 8g, Dijincao 3g.

Embodiment 2

[0018] Example 2, the weight ratio of raw materials: Astragalus 10g, Polygonatum 15g, Ligustrum lucidum 15g, Hagi 10g, Niujiaojiao 10g, Atractylodes Rhizoma 15g, Angelica 10g, 9 layers of wind 15g, Dijincao 6g.

Embodiment 3

[0019] Example 3, weight ratio of raw materials: Astragalus 8g, Polygonatum 10g, Ligustrum lucidum 10g, Hagi One Leaf 8g, Niujiaojiao 8g, Atractylodes Rhizoma 10g, Angelica sinensis 8g, Jiucaifeng 10g, Dijincao 5g.

[0020] When in use, the traditional Chinese medicine of the present invention astragalus, Huang Jing, Ligustrum lucidum, one leaf hagi, ox horn gill, Atractylodes radicle, angelica, Dijincao and Jiushengfeng are decocted twice with water, combined with the filtrate, and taken in morning and evening.

[0021] The effective combination of the above-mentioned medicines, coordinated with each other, can effectively achieve the purpose of treating aplastic anemia with less side effects. The above results are fully proved by clinical data, and the relevant data are as follows, wherein the use of the research drug is the weight ratio of the raw material drug in Example 3.

[0022] 1 Objects and methods.

[0023] 1.1 Subjects: All cases were from CAA patients who were ou...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating aplastic anemia, which is used for solving the treatment problem of aplastic anemia. The medicine is characterized by being prepared from processing various traditional Chinese medicines, and comprises the active pharmaceutical ingredients in parts by weight: 6-10 parts of astragalus, 8-15 parts of polygonatum, 8-15 parts of glossy privet fruit, 6-10 parts of flueggea suffruticosa, 6-10 parts of ox horn bone, 8-15 parts of largehead atractylodes rhizome, 6-10 parts of angelica, 8-15 parts of herba cladostachvdis and 3-6 parts of humifuse euphorbia herb. Clinical experiments show that the medicine for treating aplastic anemia has the characteristics of good curative effect and higher safety, and is worth being clinically applied and popularized.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a medicine for treating aplastic anemia. Background technique [0002] Aplastic anemia (AA) is a kind of anemia caused by the decrease or disorder of bone marrow hematopoietic function, referred to as "aplastic anemia". Mainly manifested as bone marrow hematopoietic hypofunction, pancytopenia and anemia, hemorrhage, and infection syndrome. According to the onset of acute and moderate and the severity of the disease, it can be divided into acute and chronic. The acute type is characterized by anemia that is not obvious at the beginning, often with bleeding, infection, and high fever as the first symptoms, but the disease progresses rapidly, and severe anemia occurs quickly: the bleeding is severe and extensive, not only bleeding from the skin, mucous membranes and fundus, but also Often accompanied by visceral hemorrhage; infections are more common in the mouth, phary...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8969A61P7/06
Inventor 刘加强
Owner NANTONG HONGCI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com